Indices of Severity and Prognosis for Sickle Cell Disease

NCT00005467 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-02-18

No results posted yet for this study

Summary

To develop a clinical severity index that could prospectively identify sickle cell disease patients who were at high risk for a turbulent clinical course and a poor prognosis.

Conditions

  • Anemia, Sickle Cell
  • Blood Disease

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-01-31
Completion
1992-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005467 on ClinicalTrials.gov